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Summary 
Advanced electronic alerts (eAlerts) and computerized physician order entry 
(CPOE) increase adequate thromboprophylaxis orders among hospitalized medical 
patients. It remains unclear whether eAlerts maintain their efficacy over time, after 
withdrawal of continuing medical education (CME) on eAlerts and on thromboprophylaxis 
indications from the study staff. 
We analyzed 5317 hospital cases from the University Hospital Zurich during 2006-
2009: 1854 cases from a medical ward with eAlerts (intervention group) and 3463 cases 
from a surgical ward without eAlerts (control group). In the intervention group, an eAlert 
with hospital-specific VTE prevention guidelines was issued in the electronic patient chart 
6 h after admission if no pharmacological or mechanical thromboprophylaxis had been 
ordered. Data were analyzed for three phases: pre-implementation (phase 1), eAlert 
implementation with CME (phase 2), and post-implementation without CME (phase 3). 
The rates of thromboprophylaxis in the intervention group were 43.4% in phase 1 
and 66.7% in phase 2 (p<0.001), and increased further to 73.6% in phase 3 (p=0.011). 
Early thromboprophylaxis orders within 12 hours after admission were more often placed 
in phase 2 and 3 as compared to phase 1 (67.1% vs. 52.1%, p<0.001). In the surgical 
control group, the thromboprophylaxis rates in the three phases were 88.6%, 90.7%, 
90.6% (p=0.16). 
Advanced eAlerts may provide sustained efficacy over time, with stable rates of 
thromboprophylaxis orders among hospitalized medical patients. 
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Introduction 
Deep vein thrombosis (DVT) and pulmonary embolism (PE) together are referred 
to as venous thromboembolism (VTE) (1). The DVT attack rate (incidence of first and 
recurrent DVT) has been estimated for the United States and the European Union at 
128/100,000 person-years (2) and 148/100,000 person-years (3), respectively. 
Approximately one quarter of all VTE events are hospital-related and at least 70% of the 
VTE-associated deaths occur as a consequence of a hospital-acquired VTE (3, 4). The 
case fatality rate of PE approximates 7-11% (5, 6). 
Appropriate use of prophylaxis to prevent VTE is an important strategy for 
improving safety among hospitalized patients (7, 8). A recent meta-analysis found 
significant reductions in any PE (relative risk 0.43) and fatal PE (relative risk 0.38) due to 
thromboprophylaxis without a significant increase in major bleeding complications (9). 
The American College of Chest Physicians (ACCP) has established evidence-
based guidelines for the prevention of VTE, including pharmacologic treatment with 
anticoagulants and mechanical prophylaxis (e.g. compression stockings) (10). 
Nevertheless, many patients at risk do not receive prophylaxis, as evidenced by three 
large studies (11-13). The ACCP suggests the use of various strategies for increasing 
thromboprophylaxis adherence, explicitly including the use of computer decision support 
systems (CDSS). Some studies investigated computerized reminders of prophylaxis and 
found substantially higher thromboprophylaxis rates due to electronic alerts (eAlert) (14-
16). However, lack of physician compliance with electronically generated suggestions is a 
well-known problem called ‘alert fatigue’ or ‘overriding’ (17). 
Research on VTE prevention has been a focus at the University Hospital Zurich in 
recent years in the context of an ongoing quality assurance program which also covered 
multicenter studies (18, 19). In 2007, an advanced eAlert module was developed and 
implemented into the clinical information system (KISIM, Cistec AG, Zurich, Switzerland) 
of a medical ward. An eAlert was issued in the electronic chart six hours after the patient 
was admitted to the ward if no pharmacologic or mechanical prophylaxis had been 
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ordered. All healthcare professionals involved in the patient care were reminded by a 
highlighted alert button to consider thromboprophylaxis, but only the physician was 
enabled to respond to the eAlert. When the physician clicked on the eAlert button, an 
information screen displayed hospital-specific guidelines on VTE prevention in medical 
patients. 
Physician compliance with the VTE eAlerts was evaluated in a pilot study (16). 
During this period, continuing medical education (CME) on prevention of VTE in 
hospitalized patients and on the eAlert system was provided to the staff physicians of the 
medical ward. The rate of appropriate prophylaxis during this pilot study averaged 76%, 
as compared to a much lower rate of 44% observed in a cross-sectional 1-day survey 
prior to the implementation of computerized physician order entry (CPOE) (16, 18). The 
prospective pilot study focused on physicians’ compliance. It did not consider data on the 
prophylaxis rate in patients treated in the same medical ward immediately before or after 
the study period, and no data were available on patients treated in other wards during the 
identical period, in the absence of eAlerts. 
The purpose of the present analysis was to comparatively assess the sustainability 
of the eAlert system over time. 
 
Materials and methods 
Two wards of the University Hospital of Zurich, Switzerland, introduced CPOE in 
2006, i.e. a medical ward (intervention group) and a surgical ward (control group). Then, 
CPOE was limited to these wards, including 22 beds in medicine and 23 beds in surgery, 
respectively. The remaining wards in medicine (164 beds) and surgery (239 beds) were 
not considered since they introduced CPOE not before 2009. 
In the medical intervention ward, but not in the surgical ward, an eAlert was 
displayed in the electronic chart of each patient who did not receive a pharmacological or 
mechanical thromboprophylaxis order within six hours after admission (16). Prophylaxis 
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guidelines including a VTE risk score are displayed by default when the physician 
acknowledges the eAlert button. 
All patients admitted to the study wards from April 2006 to December 2009 were 
enrolled if they stayed for at least 24 hours in these wards and (i) either entered these 
wards directly or (ii) entered these wards via the emergency department; i.e. in-patients 
transferred from other wards were excluded. The electronic charts of the included patients 
were searched for orders of pharmacological and mechanical prophylaxis. All orders of 
prophylaxis were considered for the time period from admission to discharge or transfer of 
the patient to another ward.  
We analyzed 5317 hospital cases during 2006-2009: 1854 cases from the medical 
intervention ward with eAlerts and 3463 cases from the surgical ward without eAlerts. The 
overall study period included 45 months: (a) pre-implementation phase 1, 4/2006-8/2007, 
(b) eAlerts implementation phase 2, 9/2007-12/2008, and (c) post-implementation 
phase 3, 1/2009-12/2009. The eAlert module was implemented in the intervention ward at 
the beginning of phase 2 and included monitoring of the appropriateness of the ordered 
VTE prophylaxes (16). The eAlerts remained in operation in the intervention group also 
during phase 3. Only during phase 2 was specific CME on indications for prophylaxis 
provided to the physicians of the intervention group. No specific CME was offered to the 
physicians of the control group. This quality improvement initiative study was approved by 
the local ethics committee and patient consent was waived. 
The rate of prophylaxis was defined as the percentage of patients with at least one 
order for VTE prophylaxis during their stay in the admitting ward. Combined prophylaxis 
was defined as orders of both pharmacologic and mechanical prophylaxes. 
Clinical outcome at discharge was assessed for all three phases by searching the 
patient charts for diagnoses of PE and DVT (I26.0, I26.9, I82.8, I82.9; International 
Classification of Diseases [ICD-10], World Health Organization, Geneva, Switzerland). All 
VTE diagnoses were independently adjudicated by two physicians, classifying them into 
pre-existing events and hospital-acquired complications. Hospital-acquired VTE events 
were considered if they were symptomatic and objectively confirmed by an imaging test. 
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No imaging confirmation was required for in-hospital deaths where PE was considered as 
likely cause.  
Chi-square tests of independence were used for statistical analysis of frequencies 
in 3x2 contingency tables and Fisher’s exact tests were used for 2x2 contingency tables, 
using the software EpiData V2.2.1.171 (EpiData Association, Odense, Denmark). The 
p-levels of ≤0.05 were considered significant. 
 
Results 
Cases studied 
A total of 5,317 cases with a minimal stay of 24 hours in the wards of admission 
were analyzed, including 4,156 patients. The length of stay in the admitting wards 
averaged 5.0 days, the median was 3.0 days (medical ward: average 7.4 days, median 
5.0 days, surgical ward: average 3.7 days, median 3.0 days). Thromboprophylaxis was 
prescribed in 4,232 cases during hospitalization in the two wards (79.6%). These patients 
received either pharmacological thromboprophylaxis alone (2,464 of 4,232 cases; 58.2%), 
a combination of pharmacological and mechanical measures (39.1%), or mechanical 
prophylaxis alone (2.7%).  
 
eAlert intervention 
The rate of thromboprophylaxis increased significantly after implementing the 
eAlert function in the clinical information system of the intervention group, from 43.4% 
during phase 1 to 66.7% during phase 2 (p<0.001; Tab. 1). The percentage further 
increased during phase 3 to 73.6% (p=0.011). No significant changes in the rate of 
prophylaxis were noted over the three phases in the surgical control group (p=0.16). 
During the three study phases, the number of patients with a hospital-acquired 
VTE event in the medical ward was 2 (pre-implementation), 0 (eAlerts implementation) 
and 3 (post-implementation); in the surgical ward 3, 2, 1, respectively. Analysis of the data 
of each group revealed no statistically significant changes between the study phases. 
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Timing of order entry 
Orders of VTE prophylaxis were frequently placed before planned admissions to 
the surgical ward, i.e. in patients hospitalized for elective procedures (1,898 of 
3,113 orders, 61.0%). In contrast, very few pre-admission orders were issued by 
physicians of the medical ward (19 of 1,119 orders, 1.7%). Of the 2,315 orders placed 
after admission, 51.8% were entered within the first 6 h, 23.7% within 6-12 h, and 24.5% 
at a later stage (average time of ordering after admission 15.4 h, median 5.7 h). 
After eAlert implementation, the physicians of the intervention group entered 
orders for thromboprophylaxis sooner than they did in the pre-implementation phase. The 
percentage of orders placed within 12h after admission of the patients increased from 
52.1% (146 of 280) to 67.1% (550 of 820; p<0.001) (Fig. 1). In particular, a higher 
percentage of orders were placed in the time frame 6-12 h after admission of the patients, 
i.e. during the period immediately following the eAlert activation (27.1% vs. 
35.9%; p=0.008). In contrast, no increase of orders placed 6-12 h after admission was 
observed in the control group. 
 
Discussion 
CDSS are successful in supporting preventive care (20) and offer great potential to 
assist physicians in improving the quality of treatment (21, 22). In most evaluations, the 
impact of interventions for quality assurance is assessed by comparing data observed 
during a study period with data of historic or simultaneous controls. Some studies 
documented a beneficial effect of eAlerts on thromboprophylaxis over a limited period (14-
16). One study considered whether the impact of these eAlerts on the rate of prophylaxis 
could be maintained beyond the initial study period, by comparing the long-term data with 
historic controls (23). The present study confirms a sustained effect of the eAlert system 
observed during the eAlert implementation phase by comparing the data to both the pre-
implementation phase and the post-implementation phase. 
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The VTE prophylaxis rate in the medical intervention ward remained high during 
the post-implementation phase despite cessation of specific CME and withdrawal of 
accompanying study staff. The stability in the rates of thromboprophylaxis orders, 
particularly in the rate of early orders, confirm that the physician compliance with the 
eAlert system was sufficient over time. Only in the intervention group, but not in the 
control group, did the percentage of orders within 6-12 h increase, i.e. immediately after 
activating eAlerts. 
Although eAlerts for hospitalized medical patients can not and should not produce 
thromboprophylaxis rates found in surgical patients, they improve adherence to guidelines 
and may provide sustained efficacy without evidence of alert fatigue (17) or the 
Hawthorne effect (24, 25), sometimes affecting the generalizability of clinical research. 
The rates of thromboprophylaxis obtained for the identical time periods from the surgical 
control ward were stable over time, with an average of 90%, confirming that 
thromboprophylaxis rates are higher in surgical than in medical patients (13, 26). The 
appropriateness of thromboprophylaxis was not assessed in the surgical patients, but it is 
unlikely that the introduction of eAlerts on this surgical ward would further improve the use 
of appropriate prophylaxis. 
The present study focused on the rates of thromboprophylaxis over time, 
considering neither the appropriateness of ordered prophylaxis nor the appropriateness of 
omitted prophylaxis. In fact, both underuse and overuse of VTE prophylaxis occur (18). 
The aim of CDSS is to improve adherence to guidelines for prescribing VTE prophylaxis 
and the use of institution-tailored tools has been advocated (26, 27). The adequacy of 
prophylaxis has been assessed in the intervention group during phase 2 only, resulting in 
a rate of appropriate VTE prophylaxis in 76% as compared to 44% prior to the introduction 
of CPOE (16). These numbers are in line with the impact of the eAlerts on the rate of 
prophylaxis assessed in the present analysis, showing an increase from 43% to 67% due 
to the introduction of eAlerts, up to 74% thereafter. 
Limitations of our study include that the appropriateness of prophylaxis orders and 
the VTE events following discharge were not monitored. Although the rate of appropriate 
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prophylaxis orders among medical patients was high (76%) during the eAlert 
implementation phase, we cannot rule out with certainty that this rate decreased over time 
in the post-implementation phase. However, eAlerts significantly reduced the rate of 
inappropriate VTE prophylaxis orders in a recent management study in which our 
institution participated (28). In addition, the in-hospital VTE rate was very low in both the 
medical ward (5 events in 1854 cases) and the surgical ward (6 events in 3463 cases). 
Therefore, our study was likely underpowered to detect significant differences in VTE 
rates between the three phases. 
The major increase of the thromboprophylaxis rate due to the implementation of 
eAlerts illustrates the well-known gap between clinical practice and evidence-based 
guidelines (29). Reasons for insufficient adherence to guidelines include complexity of 
guidelines, lack of physician awareness, concerns over the risk-to-benefit ratio of 
prophylaxis and lack of hospital resources (8). In particular, inexperienced interns starting 
their career in a teaching hospital may feel uncertain about ordering VTE prophylaxis. 
Thus, eAlerts may be considered as trainers for better adherence to guidelines in order to 
improve patient safety. The ACCP explicitly recommends the use of CDSS to increase 
guideline adherence (10). Linking CDSS with evidence-based risk scores and up-to-date 
guidelines may help to enhance the quality of treatment (27). 
However, lack of physician compliance with electronically generated suggestions is 
a well-known problem. Design and quality of the user interface of a clinical information 
system may contribute to its acceptance. Various strategies were proposed to limit alert 
fatigue, e.g. providing concise context-sensitive online information, reducing the number 
of alerts with low relevance, enforcing user response by interruptive alerts or by 
implementing multi-screen alerts (30). Furthermore, the specificity of an alert may be 
increased, e.g. by displaying alerts only to selected health care professionals (17, 31). 
Indeed, different strategies may be required to overcome alert fatigue, also depending on 
national or regional cultures and incentives. 
The present eAlert module was designed to reduce the number of unnecessary 
prompts. It gives the physician an adequate amount of time to place orders, and an alert is 
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issued only if no prophylaxis order has been placed within a predefined time frame after 
admission. The eAlert module does not identify high-risk patients based on calculation of 
a VTE risk score since the identification of individual risk factors by computers may be 
unreliable, particularly during the initial hospital stay, owing to incomplete or missing 
information in the patient database. However, the guidelines for prophylaxis indications 
are displayed by default when the physician acknowledges the eAlert button. 
In conclusion, advanced eAlerts for hospitalized medical patients may provide 
sustained efficacy with stable rates of thromboprophylaxis over time. 
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Legends to figures and tables 
 
Table 1: Rate of prophylaxis during three phases in an intervention ward with eAlerts 
compared to a control ward without eAlerts. 
 
Figure 1: Timing of orders for thromboprophylaxis in the medical intervention ward. 
 
Tables 
 
Table 1 
p
intervention with eAlerts medical 286 / 659
#
43.4 % 449 / 673 66.7 % 384 / 522 73.6 % <0.0001
control surgical 1129 / 1274 88.6 % 1128 / 1244 90.7 % 856 / 945 90.6 % 0.1645
cases with thromboprophylaxis / total number of cases
pre-implementation eAlert implementation post-implementation
#
 
Extra table 
 
 
What is known about this topic? 
- Appropriate use of prophylaxis to prevent VTE is an important strategy for improving 
safety among hospitalized patients.  
- Many patients at risk do not receive prophylaxis despite evidence-based guidelines. 
- Computer decision support systems can improve adherence to guidelines on 
thromboprophylaxis. However, alert fatigue may compromise the long-term impact of 
such systems. 
 
What does this paper add? 
- An advanced eAlert system did provide sustained efficacy over time, resulting in 
enhanced rates of thromboprophylaxis orders among hospitalized medical patients. 
- Cessation of specific continuing medical education and withdrawal of accompanying 
study staff did not reduce the prophylaxis rate. 
- Orders were entered sooner as a result of good physician compliance with the eAlert 
system. 
 
 
Figures 
Figure 1 
phase 1 phase 2 phase 3
Prophylaxis ordered before admission 6 8 5
Prophylaxis ordered 0-6h after admission 70 126 130
Prophylaxis ordered 6-12h after admission 76 151 143
Prophylaxis ordered >12h after admission 134 164 106
No prophylaxis 373 224 138
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